Literature DB >> 9252396

Regulation of protein kinase Cmu by basic peptides and heparin. Putative role of an acidic domain in the activation of the kinase.

M Gschwendt1, F J Johannes, W Kittstein, F Marks.   

Abstract

Protein kinase Cmu is a novel member of the protein kinase C (PKC) family that differs from the other isoenzymes in structural and enzymatic properties. No substrate proteins of PKCmu have been identified as yet. Moreover, the regulation of PKCmu activity remains obscure, since a structural region corresponding to the pseudosubstrate domains of other PKC isoenzymes has not been found for PKCmu. Here we show that aldolase is phosphorylated by PKCmu in vitro. Phosphorylation of aldolase and of two substrate peptides by PKCmu is inhibited by various proteins and peptides, including typical PKC substrates such as histone H1, myelin basic protein, and p53. This inhibitory activity seems to depend on clusters of basic amino acids in the protein/peptide structures. Moreover, in contrast to other PKC isoenzymes PKCmu is activated by heparin and dextran sulfate. Maximal activation by heparin is about twice and that by dextran sulfate four times as effective as maximal activation by phosphatidylserine plus 12-O-tetradecanoylphorbol-13-acetate, the conventional activators of c- and nPKC isoforms. We postulate that PKCmu contains an acidic domain, which is involved in the formation and stabilization of an active state and which, in the inactive enzyme, is blocked by an intramolecular interaction with a basic domain. This intramolecular block is thought to be released by heparin and possibly also by 12-O-tetradecanoylphorbol-13-acetate/phosphatidylserine, whereas basic peptides and proteins inhibit PKCmu activity by binding to the acidic domain of the active enzyme.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252396     DOI: 10.1074/jbc.272.33.20742

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Regulation of protein kinase D1 activity.

Authors:  Susan F Steinberg
Journal:  Mol Pharmacol       Date:  2011-12-21       Impact factor: 4.436

2.  Characterization of calreticulin as a protein interacting with protein kinase C.

Authors:  E Rendón-Huerta; G Mendoza-Hernández; M Robles-Flores
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

3.  Transient dynamic actin cytoskeletal change stimulates the osteoblastic differentiation.

Authors:  Chikahisa Higuchi; Norimasa Nakamura; Hideki Yoshikawa; Kazuyuki Itoh
Journal:  J Bone Miner Metab       Date:  2009-01-30       Impact factor: 2.626

4.  Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone.

Authors:  Elizabeth R Sharlow; Karthik V Giridhar; Courtney R LaValle; Jun Chen; Stephanie Leimgruber; Rebecca Barrett; Karla Bravo-Altamirano; Peter Wipf; John S Lazo; Q Jane Wang
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

5.  Regulatory domain determinants that control PKD1 activity.

Authors:  Vitalyi O Rybin; Jianfen Guo; Erin Harleton; Fan Zhang; Susan F Steinberg
Journal:  J Biol Chem       Date:  2012-05-11       Impact factor: 5.157

6.  Structural requirements for localization and activation of protein kinase C mu (PKC mu) at the Golgi compartment.

Authors:  Angelika Hausser; Gisela Link; Linda Bamberg; Annett Burzlaff; Sylke Lutz; Klaus Pfizenmaier; Franz-Josef Johannes
Journal:  J Cell Biol       Date:  2002-01-03       Impact factor: 10.539

Review 7.  Function and Regulation of Protein Kinase D in Oxidative Stress: A Tale of Isoforms.

Authors:  Mathias Cobbaut; Johan Van Lint
Journal:  Oxid Med Cell Longev       Date:  2018-04-26       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.